The authors emphasize the need for more sensitive biomarkers beyond traditional proteinuria, highlighting emerging candidates such as urinary podocalyxin, KIM-1, NGAL, GluAp, and podocin as promising indicators of early glomerular and tubular damage in children with obesity. Here, LCN2 is linked to obesity disorder.